Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
5.89
-0.04 (-0.59%)
At close: Dec 5, 2025, 4:00 PM EST
5.77
-0.12 (-1.95%)
After-hours: Dec 5, 2025, 4:10 PM EST
Kalaris Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -55.47 | -69.17 | -14.7 | -15.49 |
| Other Amortization | 36.07 | 38.02 | 0.89 | 1.99 |
| Asset Writedown & Restructuring Costs | - | - | - | 0.16 |
| Stock-Based Compensation | 1.88 | 0.9 | 0.15 | 0.27 |
| Other Operating Activities | -21.07 | 11.71 | 0.62 | -0.11 |
| Change in Accounts Payable | -1.86 | -1.03 | -0.4 | 1.83 |
| Change in Other Net Operating Assets | 1.36 | -1.1 | -0.69 | 1.57 |
| Operating Cash Flow | -39.16 | -20.67 | -14.13 | -9.78 |
| Short-Term Debt Issued | - | 19.97 | - | - |
| Long-Term Debt Issued | - | - | 6 | 4.3 |
| Total Debt Issued | 17.47 | 19.97 | 6 | 4.3 |
| Net Debt Issued (Repaid) | 17.47 | 19.97 | 6 | 4.3 |
| Issuance of Common Stock | 0 | 0 | - | 0.01 |
| Other Financing Activities | 97.37 | -2.42 | - | - |
| Financing Cash Flow | 114.84 | 19.14 | 14.24 | 12.78 |
| Net Cash Flow | 40.97 | -1.53 | 0.11 | 3 |
| Levered Free Cash Flow | -12.82 | -18.82 | -9.43 | - |
| Unlevered Free Cash Flow | -24.62 | -31.39 | -9.34 | - |
| Change in Working Capital | -0.51 | -2.13 | -1.09 | 3.4 |
Source: S&P Capital IQ. Standard template.
Financial Sources.